HomeCompareESTTF vs MRK

ESTTF vs MRK: Dividend Comparison 2026

ESTTF yields 8.11% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ESTTF wins by $3446.02M in total portfolio value
10 years
ESTTF
ESTTF
● Live price
8.11%
Share price
$8.14
Annual div
$0.66
5Y div CAGR
84%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3446.07M
Annual income
$3,267,836,418.00
Full ESTTF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — ESTTF vs MRK

📍 ESTTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESTTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESTTF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESTTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESTTF
Annual income on $10K today (after 15% tax)
$689.19/yr
After 10yr DRIP, annual income (after tax)
$2,777,660,955.30/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, ESTTF beats the other by $2,777,652,358.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESTTF + MRK for your $10,000?

ESTTF: 50%MRK: 50%
100% MRK50/50100% ESTTF
Portfolio after 10yr
$1723.07M
Annual income
$1,633,923,265.89/yr
Blended yield
94.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ESTTF
No analyst data
Altman Z
3.9
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESTTF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESTTFMRK
Forward yield8.11%2.81%
Annual dividend / share$0.66$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR84%32.7%
Portfolio after 10y$3446.07M$57.7K
Annual income after 10y$3,267,836,418.00$10,113.78
Total dividends collected$3433.31M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ESTTF vs MRK ($10,000, DRIP)

YearESTTF PortfolioESTTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,192$1,491.89$11,213$373.04+$979.00ESTTF
2$16,173$3,127.83$12,667$512.06+$3.5KESTTF
3$24,440$7,135.10$14,439$708.14+$10.0KESTTF
4$44,693$18,541.60$16,640$988.16+$28.1KESTTF
5$106,127$58,305.71$19,432$1,394.07+$86.7KESTTF
6$351,642$238,085.79$23,057$1,992.90+$328.6KESTTF
7$1,732,826$1,356,569.29$27,889$2,894.79+$1.70MESTTF
8$13,349,696$11,495,572.39$34,518$4,286.29+$13.32MESTTF
9$166,577,579$152,293,404.54$43,912$6,494.35+$166.53MESTTF
10$3,446,074,428$3,267,836,418.00$57,714$10,113.78+$3446.02MESTTF

ESTTF vs MRK: Complete Analysis 2026

ESTTFStock

Estore Corporation operates as an e-commerce (EC) support services company in Japan. The company offers SellSide solution that provides total solutions, such as search engines, recommendation engines, and data centers; Shopserve solution to see orders, deposits, and delivery status, as well as process payments and send emails; E store compare, which discovers optimal design and display rate setting; and E store query, a mail marketing system. It also provides survey analysis that include in-house analysis, market research, competitive investigation, and EC clinic services; and design strategy services, including planning, moving, and consulting services. In addition, the company offers promotion services that include listing ads, display, feed, affiliate, and SNS advertising; creative services, including PC/smartphone site production, special LP production, photo shoot, copywriting, and video ads; and fulfillment services, such as order processing, inventory registration, product registration, payment processing, logistics support, and call center services. Estore Corporation was incorporated in 1999 and is headquartered in Tokyo, Japan.

Full ESTTF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ESTTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESTTF vs SCHDESTTF vs JEPIESTTF vs OESTTF vs KOESTTF vs MAINESTTF vs JNJESTTF vs ABBVESTTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.